Karma Biotechnologies
PrivateLast Round
Accelerator
Oct 26, 2023
Total Funding Raised
$500,000
Company Overview
Karma Biotechnologies is a biotechnology company that develops tolerogenic therapeutics and immunotherapy solutions to treat autoimmune diseases, allergies, and food sensitivities.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Karma Biotechnologies Comparables
Compare Karma Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ahead Therapeutics | 77% | |
| AbbVie | 77% | |
| Parvus Therapeutics Inc. | 76% |
Karma Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Oct 26, 2023 | ||||
| Grant | Jan 10, 2022 | ||||
| Seed | Oct 14, 2015 |
Karma Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Accelerator |
| Tech Coast Angels | Accelerator |
| IndieBio | Seed, Accelerator |
| SOSV | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors increased 50% MoM to 122.2K.
Karma Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Karma Biotechnologies's valuation, stock price, and market status.
Is Karma Biotechnologies a public or private company?
Karma Biotechnologies is a private company.
What is the current stock price of Karma Biotechnologies?
Karma Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Karma Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Karma Biotechnologies worth (valuation)?
Valuation information for Karma Biotechnologies is not publicly available.
Can I buy Karma Biotechnologies stock?
Karma Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Karma Biotechnologies's last funding round?
Karma Biotechnologies's most recent funding round was Accelerator on October 26, 2023.
Who are the main investors in Karma Biotechnologies?
Key investors in Karma Biotechnologies include IndieBio.
Will Karma Biotechnologies IPO soon?
No public IPO plans have been announced for Karma Biotechnologies.
How can I track Karma Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Karma Biotechnologies's shares on secondary markets.